Zevra Therapeutics: A High-Stakes Bet in the Ultra-Rare Disease Arena

The Silent Storm: Why Antimicrobial Resistance Threatens Everything We Know About Medicine

Prime: Unlocking a Brighter Future for Wilson's Disease and Beyond

Unpacking the Data: InflaRx's Continued Deep Dive into Vilobelimab for Pyoderma Gangrenosum

InflaRx's Vilobelimab: A Deeper Look into Pyoderma Gangrenosum Trial Data

The Dawn of AI-Driven Cures: Insilico Medicine's Historic Hong Kong Debut

A New Horizon for Essential Tremor: Praxis's Ulixacaltamide Earns Breakthrough Status

The Biotech Buzz: Is Abivax Poised to Be the Next Big Acquisition?

A Game-Changer for Assembly Bio: Gilead's Nod Sends Stock Soaring

The Silent Crisis: How Gonorrhea is Slipping Past Our Last-Ditch Drugs

Terns Pharmaceuticals Soars: A New Dawn for Tough-to-Treat Leukemia Patients?

ASH 2025: Glimmers of Hope and Big Strides in Blood Disorders

A Glimmer of Hope: Syndax's Novel AML Drug Shines Bright at ASH Meeting

The Bittersweet Breakthrough: Gertrude Elion's Pioneering Drug in the Fight Against Childhood Leukemia

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

The Anticipation Builds: ASH 2025 and the Evolving Landscape of Blood Cancer Therapies

The Unyielding Riddle of Alzheimer's: Why Progress Feels So Elusive

Malaria's Hidden Strategy: Unmasking the Parasite's Corkscrew Journey Through Our Skin

Cassava Sciences' Simufilam Trial Faces Fresh FDA Scrutiny

The Enduring Quest: Semaglutide and the Unyielding Challenge of Alzheimer's

Wockhardt's Game-Changer: India's First Homegrown NCE Accepted by USFDA – A New Dawn?

Regeneron and Tessera Forge Potent Alliance for Next-Generation Gene Editing Therapies

The Looming Shadow: Why Our New Plan to Fight Antimicrobial Resistance Needs a Serious Boost

A New Chapter in Rare Disease Treatment: Omeros and Novo Nordisk Finalize Landmark Zaltenibart Deal

A Beacon of Hope: Reviva Pharmaceuticals' Brilaroxazine Achieves Pivotal Milestones in Schizophrenia Treatment

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

AI Drug Discovery Takes a Giant Leap: Iambic Therapeutics Secures $100M

The Shifting Tides: Is Animal Testing Nearing Its End?

A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance

Amycretin: Is Novo Nordisk's Oral Wonder Drug the Future of Weight Loss and Diabetes Treatment?

Novo Nordisk's Alzheimer's Trial Setback: A Closer Look

Tonix Pharmaceuticals Gets the Go-Ahead: TNX-102 Enters Clinical Development for Major Depression

The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

The Evolving Landscape of Biotech Innovation and Investment

A Glimmer of Hope? Telo Genomics Stock Jumps as Early Study Shows Leukemia Cell Death

The Shifting Sands of Biotech M&A: Navigating a New Era with Veteran Insight

The FDA's Golden Ticket: A Moral Maze in Drug Development